Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
University College London Hospitals
Scientific Title
International Phase III Randomised Study to Evaluate the Efficacy of Maintenance Therapy With Olaparib and Cediranib or Olaparib Alone in Patients With Relapsed Ovarian Cancer Following a Response to Platinum-based Chemotherapy